Article
Copy Number Variations in a Cohort of 420 Individuals with Neurodevelopmental Disorders From the South of Brazil
28 Nov 2019
Abstract excerpt
Chromosomal microarray (CMA) is now recommended as first tier for the evaluation in individuals with unexplained neurodevelopmental disorders (ND). However, in developing countries such as Brazil, classical cytogenetic tests are still the most used in clinical practice, as reflected by the scarcity of publications of microarray investigation in larger cohorts. This is a retrospective study which analyses the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
